April 24, 2026 05:32 AM EDTUpdated 09:42 AM PharmaManufacturing Daiichi Sankyo postpones annual results, stock dips Elizabeth Cairns Senior biopharma journalist Daiichi Sankyo has pushed back the reporting of its annual results, saying it needs more time to finalize the numbers. The Japanese company had intended … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
81 words · extracted 2mo agoread original ↗
comments(0)
5-min edit window · permanent after that